Search results
AstraZeneca admits in court documents that COVID-19 vaccine could cause serious rare side effect
Just the News· 16 hours agoBritish pharmaceutical company AstraZeneca admitted in court documents for the first time that its...
Fusion Pharmaceuticals Inc. (FUSN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 2 hours agoFusion Pharmaceuticals (FUSN) possesses the right combination of the two key ingredients for a...
Recursion Pharmaceuticals, Inc. (RXRX) is Attracting Investor Attention: Here is What You Should...
Zacks via Yahoo Finance· 3 hours agoZacks.com users have recently been watching Recursion Pharmaceuticals (RXRX) quite a bit. Thus, it...
Earnings call: Jazz Pharmaceuticals sustains growth with key drivers By Investing.com
Investing.com· 5 hours agoJazz Pharmaceuticals PLC (NASDAQ:JAZZ) has reported robust first-quarter 2024 results, showcasing...
PHL firms cited for giving Filipinos access to COVID-19 medicine - BusinessWorld Online
BusinessWorld· 4 hours agoTWO Philippine pharmaceutical companies under the AC Health group were recognized in Asia for easing...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 9 hours agoJohnson & Johnson – $15.09bn In 2023 Johnson & Johnson (J&J) displayed strong financial growth and was the leading pharmaceutical company in terms of...
Stock Traders Buy High Volume of Xenon Pharmaceuticals Put Options (NASDAQ:XENE)
ETF DAILY NEWS· 14 hours agoXenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) saw unusually large options trading on Wednesday. Stock investors purchased 4,063 put options on the stock. Xenon ...
Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be...
Simply Wall St. via Yahoo Finance· 4 hours agoSummary Overall, we are quite pleased with Regeneron Pharmaceuticals' performance. Particularly, we...
CB Therapeutics Unveils Revolutionary Breakthroughs in Crafting Pharmaceutical-Grade Cannabinoids...
Digital Journal· 2 hours agoWith the recent reclassification of cannabinoids, the company hopes to revolutionize the pharmaceutical industry by offering a sustainable, standardized ...
Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 4 hours agoAgios Pharmaceuticals (AGIO) delivered earnings and revenue surprises of 11.59% and 2.56%,...
